Orion Biotechnology is a clinical stage biotechnology company developing novel medical treatments.
Orion Biotechnology has raised $6.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Orion Biotechnology's investors include Side Door Ventures, Keiretsu Capital, Keiretsu Forum, SevenTrainVentures, National Center for Research & Development.
Orion Biotechnology is headquartered in Ottawa, Canada.
Orion Biotechnology is a clinical stage biotechnology company developing novel medical treatments.
Orion Biotechnology is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orion Biotechnology — Funding & Investors." VCBacked, July 23, 2024, https://www.vcbacked.co/company/orion-biotechnology. Accessed July 19, 2026.
VCBacked. (2024). Orion Biotechnology — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/orion-biotechnology
{{cite web |title=Orion Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/orion-biotechnology |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated